Wockhardt shares surge 40% in 5 days on anticipation of antibiotic launch

Open Demat A/C

Wockhardt antibiotic treats cancer patient in US: Milestone achievement for Zaynich (WCK 5222)

Open Demat A/C

Wockhardt applies for Nafithromycin approval from the Drug Controller General of India to treat pneumonia

Open Demat A/C

Market expansion strategy: Wockhardt targeting a $1.5 billion opportunity in developed countries and $263 million in developing markets

Open Demat A/C

With Our Subscription Plans

Open demat account in 5 minutes*

Open Demat A/C
G-L92HWH8MZR